Five years after Shire deal, Takeda looks to reap rewards of latest reinvention

Five years ago this month, Takeda Pharmaceuticals completed a $62 billion acquisition of Shire — one of the largest deals in pharmaceutical industry history. The anniversary has resurfaced scrutiny over the buyout’s value and mixed results.